Cognitive effects of hormone therapy in men with prostate cancer: A review

Cancer

Volumn 113, Issue 5, 2008, Pages 1097-1106

  Nelson, Christian J ^a   Lee, Jennifer S ^b   Gamboa, Maria C ^a   Roth, Andrew J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Altered cognitive function; Androgen ablation; Dihydrotestosterone; Estradiol; Prostate cancer; Quality of life; Testosterone

Indexed keywords

ANDROGEN; ANDROSTANOLONE; CYPROTERONE ACETATE; ESTRADIOL; GOSERELIN; HORMONE; LEUPRORELIN; TESTOSTERONE; ANTIANDROGEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

AGING; ARTICLE; AWARENESS; BRAIN; BRAIN FUNCTION; COGNITION; CORRELATION ANALYSIS; DATA BASE; DEPTH PERCEPTION; DRUG MECHANISM; DRUG USE; HORMONAL THERAPY; HUMAN; INFORMATION SCIENCE; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDLINE; NONHUMAN; PATIENT MONITORING; PHYSICIAN; PRIORITY JOURNAL; PROSTATE CANCER; SAMPLE SIZE; THERAPY EFFECT; VERBAL MEMORY; ANIMAL; BLOOD; DRUG EFFECT; MALE; NEOPLASM; PROSTATE TUMOR; QUALITY OF LIFE; REVIEW;

ANDROGEN ANTAGONISTS; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; COGNITION; HUMANS; MALE; NEOPLASMS, HORMONE-DEPENDENT; PROSTATIC NEOPLASMS; QUALITY OF LIFE; TESTOSTERONE;

EID: 52049122207     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23658     Document Type: Article

References (56)

1. Rashid MH, Chaudhary UB. Intermittent androgen deprivation therapy for prostate cancer. Oncologist. 2004;9:295-301.
2. Miyamoto H, Messing EM, Chang C. Androgen deprivation therapy for prostate cancer: current status and future prospects. Prostate. 2004;61:332-353.
3. Loblaw DA, Virgo KS, Nam R, et al. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2007;25:1596-1605.
4. Pomerantz M, Kantoff P. Advances in the treatment of prostate cancer. Annu Rev Med. 2007;58:205-220.
5. Barrass BJ, Thurairaja R, Persad RA. More should be done to prevent the harmful effects of long-term androgen ablation therapy in prostate cancer. BJU Int. 2004;93:1175-1176.
6. Bolla M, Collette L, Blank L, et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial.[see comment]. Lancet. 2002;360:103-106.
7. Bolla M, de Reijke TM, Zurlo A, Collette L. Adjuvant hormone therapy in locally advanced and localized prostate cancer: 3 EORTC trials. Front Radiat Ther Oncol. 2002;36:81-86.
8. Holzbeierlein JM, Castle E, Thrasher JB. Complications of androgen deprivation therapy: prevention and treatment. Oncology (Huntington). 2004;18:303-309; discussion 310.
9. Herr HW, O'Sullivan M. Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy. J Urol. 2000;163:1743-1746.
10. Thompson CA, Shanafelt TD, Loprinzi CL. Andropause: symptom management for prostate cancer patients treated with hormonal ablation. Oncologist. 2003;8:474-487.
11. Keating NL, O'Malley AJ, Smith MR. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol. 2006;24:4448-4456.
12. D'Amico AV, Denham JW, Crook J, et al. Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions. J Clin Oncol. 2007;25:2420-2425.
13. Salminen EK, Portin RI, Koskinen A, Helenius H, Nurmi M. Associations between serum testosterone fall and cognitive function in prostate cancer patients. Clin Care Res. 2004;10:7575-7582.
14. Sherwin BB. Steroid hormones and cognitive functioning in aging men: a mini-review. J Mol Neurosci. 2003;20:385-393.
15. Plymate SR, Tenover JS, Bremner WJ. Circadian variation in testosterone, sex hormone-binding globulin, and calculated nonsex hormone-binding globulin bound testosterone in healthy young and elderly men. J Androl. 1989;10:366-371.
16. Sherwin BB. Estrogen and cognitive functioning in men with mild cognitive impairment. J Mol Neurosci. 2002;19:219-223.
17. Cherrier MMM. Androgens and cognitive function. J Endocrinologic Invest. 2005;28(3 suppl):65-75.
18. Naftolin F, Ryan KJ, Davies IJ, et al. The formation of estrogens by central neuroendocrine tissues. Recent Prog Horm Res. 1975;31:295-319.
19. Cherrier MM, Plymate S, Mohan S, et al. Relationship between testosterone supplementation and insulin-like growth factor-I levels and cognition in healthy older men. Psychoneuroendocrinology. 2004;29:65-82.
20. Yaffe K. Testosterone and the brain: uncharted territory [letter]. Lancet Neurol. 2004;3:270.
21. Yaffe K, Grady D, Pressman A, Cummings S. Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women.[see comment]. J Am Geriatr Soc. 1998;46:816-821.
22. Wefel JS, Kayl AE, Meyers CA. Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target. Br J Cancer. 2004;90:1691-1696.
23. Yaffe K, Lui LY, Zmuda J, Cauley J. Sex hormones and cognitive function in oldermen. J Am Geriatr Soc. 2002;50: 707-712.
24. Yaffe K, Edwards ER, Lui LY, Zmuda JM, Ferrell RE, Cauley JA. Androgen receptor CAG repeat polymorphism is associated with cognitive function in older men. Biol Psychiatry. 2003;54:943-946.
25. Sandstrom NJ, Kim JH, Wasserman MA. Testosterone modulates performance on a spatial working memory task in male rats. Horm Behav. 2006;50:18-26.
26. Leranth C, Petnehazy O, MacLusky NJ. Gonadal hormones affect spine synaptic density in the CA1 hippocampal subfield of male rats. J Neurosci. 2003;23:1588-1592.
27. MacLusky NJ, Hajszan T, Prange-Kiel J, Leranth C. Androgen modulation of hippocampal synaptic plasticity. Neuroscience. 2006;138:957-965.
28. Edinger KL, Frye CA. Testosterone's analgesic, anxiolytic, and cognitive-enhancing effects may be due in part to actions of its 5alpha-reduced metabolites in the hippocampus. Behav Neurosci. 2004;118:1352-1364.
29. Frye CA, Edinger KL, Seliga AM, Wawrzycki JM. 5alphareduced androgens may have actions in the hippocampus to enhance cognitive performance of male rats. Psychoneuroendocrinology. 2004;29:1019-1027.
30. Daniel JM, Winsauer PJ, Moerschbaecher JM. Castration in rats impairs performance during acquisition of a working memory task and exacerbates deficits in working memory produced by scopolamine and mecamylamine. Psychopharmacology (Berlin). 2003;170:294-300.
31. Gibbs RB. Testosterone and estradiol produce different effects on cognitive performance in male rats. Horm Behav. 2005;48:268-277.
32. Bimonte-Nelson HA, Singleton RS, Nelson ME, et al. Testosterone, but not nonaromatizable dihydrotestosterone, improves working memory and alters nerve growth factor levels in aged male rats. Exp Neurol. 2003;181:301-312.
33. Johnson RT, Burk JA. Effects of gonadectomy and androgen supplementation on attention in male rats. Neurobiol Learn Mem. 2006;85:219-227.
34. Leonard ST, Moerschbaecher JM, Winsauer PJ. Testosterone potentiates scopolamine-induced disruptions of nonspatial learning in gonadectomized male rats. Exp Clin Psychopharmacol. 2007;15:48-57.
35. Flood JF, Farr SA, Kaiser FE, La Regina M, Morley JE. Age-related decrease of plasma testosterone in SAMP8 mice: replacement improves age-related impairment of learning and memory. Physiol Behav. 1995;57:669-673.
36. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR; Baltimore Longitudinal Study of Aging. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001;86:724-731.
37. Alexandersen P, Christiansen C. The aging male: testosterone deficiency and testosterone replacement. An up-date. Atherosclerosis. 2004;173:157-169.
38. Hampson E. Spatial cognition in humans: possible modulation by androgens and estrogens. J Psychiatry Neurosci. 1995;20:397-404.
39. Barrett-Connor E, Goodman-Gruen D, Patay B. Endogenous sex hormones and cognitive function in older men. J Clin Endocrinol Metab. 1999;84:3681-3685.
40. Hogervorst E, De Jager C, Budge M, Smith AD. Serum levels of estradiol and testosterone and performance in different cognitive domains in healthy elderly men and women. Psychoneuroendocrinology. 2004;29:405-421.
41. Carlson LE, Sherwin BB. Higher levels of plasma estradiol and testosterone in healthy elderly men compared with age-matched women may protect aspects of explicit memory. Menopause. 2000;7:168-177.
42. Janowsky JS, Chavez B, Orwoll E. Sex steroids modify working memory. J Cognitive Neurosci. 2000;12:407-414.
43. Alexander GM, Swerdloff RS, Wang C, et al. Androgen-behavior correlations in hypogonadal men and eugonadal men. II. Cognitive abilities. Horm Behav. 1998;33:85-94.
44. Wolf OT, Preut R, Hellhammer DH, Kudielka BM, Schurmeyer TH, Kirschbaum C. Testosterone and cognition in elderly men: a single testosterone injection blocks the practice effect in verbal fluency, but has no effect on spatial or verbal memory. Biol Psychiatry. 2000;47:650-654.
45. Cherrier MM, Asthana S, Plymate S, et al. Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology. 2001;57:80-88.
46. Cherrier MM, Matsumoto AM, Amory JK, et al. The role of aromatization in testosterone supplementation: effects on cognition in older men. Neurology. 2005;64:290-296.
47. Cherrier MM, Matsumoto AM, Amory JK, et al. Characterization of verbal and spatial memory changes from moderate to supraphysiological increases in serum testosterone in healthy older men. Psychoneuroendocrinology. 2007;32:72-79.
48. Green HJ, Pakenham KI, Headley BC, et al. Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial. [see comment]. BJU Int. 2002;90:427-432.
49. Cherrier MM, Rose AL, Higano C. The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer.[see comment]. J Urol. 2003;170:1808-1811.
50. Almeida OP, Waterreus A, Spry N, Flicker L, Martins RN. One-year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory, and depression in men. Psychoneuroendocrinology. 2004;29:1071-1081.
51. Salminen EK, Portin RI, Koskinen AI, Helenius HY, Nurmi MJ. Estradiol and cognition during androgen deprivation in men with prostate carcinoma. Cancer. 2005;103:1381-1387.
52. Bussiere JR, Beer TM, Neiss MB, Janowsky JS. Androgen deprivation impairs memory in older men. Behav Neurosci. 2005;119:1429-1437.
53. Beer TM, Bland LB, Bussiere JR, et al. Testosterone loss and estradiol administration modify memory in men. J Urol. 2006;175:130-135.
54. Jenkins VA, Bloomfield DJ, Shilling VM, Edginton TL. Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study. BJU Int. 2005;96:48-53.
55. Joly F, Alibhai SM, Galica J, et al. Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer. J Urol. 2006;176(6 pt 1):2443-2447.
56. Correa D, Ahles T. Cognitive adverse effects of chemotherapy in breast cancer patients. Curr Opin Support Palliat Care. 2007;1:57-62.